• Je něco špatně v tomto záznamu ?

Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development

J. Srbek, B. Klejdus, M. Douša, J. Břicháč, P. Stasiak, J. Reitmajer, L. Nováková,

. 2014 ; 130 (-) : 518-26.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023089

In this study, direct analysis in real time-mass spectrometry (DART-MS) was assessed for the analysis of various pharmaceutical formulations with intention to summarize possible applications for the routine pharmaceutical development. As DART is an ambient ionization technique, it allows direct analysis of pharmaceutical samples in solid or liquid form without complex sample preparation, which is often the most time-consuming part of the analytical method. This makes the technique suitable for many application fields, including pharmaceutical drug development. DART mass spectra of more than twenty selected tablets and other common pharmaceutical formulations, i.e. injection solutions, ointments and suppositories developed in the pharmaceutical industry during several recent years are presented. Moreover, as thin-layer chromatography (TLC) is still very popular for the monitoring of the reactions in the synthetic chemistry, several substances were analyzed directly from the TLC plates to demonstrate the simplicity of the technique. Pure substance solutions were spotted onto a TLC plate and then analyzed with DART without separation. This was the first DART-MS study of pharmaceutical dosage forms using DART-Orbitrap combination. The duration of sample analysis by the DART-MS technique lasted several seconds, allowing enough time to collect sufficient number of data points for compound identification. The experimental setup provided excellent mass accuracy and high resolution of the mass spectra which allowed unambiguous identification of the compounds of interest. Finally, DART mass spectrometry was also used for the monitoring of the selected impurity distribution in the atorvastatin tablets. These measurements demonstrated DART to be robust ionization technique, which provided easy-to-interpret mass spectra for the broad range of compounds. DART has high-throughput potential for various types of pharmaceutical analyses and therefore eliminates the time for sample cleanup and chromatographic separation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023089
003      
CZ-PrNML
005      
20150709122415.0
007      
ta
008      
150709s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.talanta.2014.07.007 $2 doi
035    __
$a (PubMed)25159441
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Srbek, Jan $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: jan.srbek@zentiva.cz.
245    10
$a Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development / $c J. Srbek, B. Klejdus, M. Douša, J. Břicháč, P. Stasiak, J. Reitmajer, L. Nováková,
520    9_
$a In this study, direct analysis in real time-mass spectrometry (DART-MS) was assessed for the analysis of various pharmaceutical formulations with intention to summarize possible applications for the routine pharmaceutical development. As DART is an ambient ionization technique, it allows direct analysis of pharmaceutical samples in solid or liquid form without complex sample preparation, which is often the most time-consuming part of the analytical method. This makes the technique suitable for many application fields, including pharmaceutical drug development. DART mass spectra of more than twenty selected tablets and other common pharmaceutical formulations, i.e. injection solutions, ointments and suppositories developed in the pharmaceutical industry during several recent years are presented. Moreover, as thin-layer chromatography (TLC) is still very popular for the monitoring of the reactions in the synthetic chemistry, several substances were analyzed directly from the TLC plates to demonstrate the simplicity of the technique. Pure substance solutions were spotted onto a TLC plate and then analyzed with DART without separation. This was the first DART-MS study of pharmaceutical dosage forms using DART-Orbitrap combination. The duration of sample analysis by the DART-MS technique lasted several seconds, allowing enough time to collect sufficient number of data points for compound identification. The experimental setup provided excellent mass accuracy and high resolution of the mass spectra which allowed unambiguous identification of the compounds of interest. Finally, DART mass spectrometry was also used for the monitoring of the selected impurity distribution in the atorvastatin tablets. These measurements demonstrated DART to be robust ionization technique, which provided easy-to-interpret mass spectra for the broad range of compounds. DART has high-throughput potential for various types of pharmaceutical analyses and therefore eliminates the time for sample cleanup and chromatographic separation.
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a chromatografie na tenké vrstvě $x metody $7 D002855
650    12
$a objevování léků $7 D055808
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a léčivé přípravky $x analýza $x chemie $7 D004364
650    _2
$a tablety $x chemie $7 D013607
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Klejdus, Bořivoj $u Institute of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1, 613 00 Brno, Czech Republic; CEITEC - Central European Institute of Technology, Mendel University in Brno, Zemědělská 1, 613 00 Brno, Czech Republic.
700    1_
$a Douša, Michal $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
700    1_
$a Břicháč, Jiří $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Stasiak, Pawel $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Reitmajer, Josef $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Nováková, Lucie $u Department of Analytical Chemistry, Charles University, Faculty of Pharmacy, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
773    0_
$w MED00004484 $t Talanta $x 1873-3573 $g Roč. 130, č. - (2014), s. 518-26
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25159441 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150709122434 $b ABA008
999    __
$a ok $b bmc $g 1083427 $s 906082
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 130 $c - $d 518-26 $i 1873-3573 $m Talanta $n Talanta $x MED00004484
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...